2443 — Lead Data Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual income statement for Lead Data, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
C2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,187 | 690 | 489 | 210 | 22.7 |
| Cost of Revenue | |||||
| Gross Profit | 11.5 | -119 | -67.8 | -21.1 | -24.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,487 | 1,018 | 929 | 342 | 119 |
| Operating Profit | -300 | -328 | -440 | -131 | -96 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -346 | -290 | -449 | -110 | 68.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -346 | -290 | -449 | -110 | 68.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -388 | -276 | -443 | -106 | 69.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -388 | -276 | -443 | -106 | 69.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.36 | -1.97 | -1.73 | -0.713 | 0.165 |
| Dividends per Share |